KWMG
PFE icon

King Wealth Management Group’s Pfizer PFE Stock Holding History

King Wealth Management Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$540K Sell
19,221
-356
-2% -$9.48K 0.07% 98
2025
Q4 		$487K Buy
19,577
+8,576
+78% +$216K 0.06% 106
2025
Q3 		$280K Sell
11,001
-304
-3% -$7.5K 0.04% 132
2025
Q2 		$274K Sell
11,305
-687
-6% -$16K 0.04% 130
2025
Q1 		$304K Sell
11,992
-945
-7% -$24.7K 0.05% 124
2024
Q4 		$343K Sell
12,937
-1,216
-9% -$33K 0.05% 111
2024
Q3 		$410K Sell
14,153
-1,041
-7% -$30.4K 0.06% 99
2024
Q2 		$425K Sell
15,194
-1,302
-8% -$35.8K 0.07% 94
2024
Q1 		$458K Sell
16,496
-190
-1% -$5.27K 0.08% 88
2023
Q4 		$480K Buy
16,686
+388
+2% +$11.7K 0.09% 85
2023
Q3 		$541K Sell
16,298
-113
-0.7% -$4K 0.11% 74
2023
Q2 		$602K Buy
16,411
+645
+4% +$25.1K 0.12% 72
2023
Q1 		$643K Sell
15,766
-67
-0.4% -$2.89K 0.14% 68
2022
Q4 		$811K Buy
15,833
+13
+0.1% +$623 0.19% 62
2022
Q3 		$692K Buy
15,820
+104
+0.7% +$5.05K 0.18% 64
2022
Q2 		$824K Sell
15,716
-14
-0.1% -$713 0.2% 62
2022
Q1 		$814K Buy
15,730
+4
+0% +$208 0.16% 69
2021
Q4 		$929K Buy
15,726
+834
+6% +$41.3K 0.17% 65
2021
Q3 		$641K Buy
14,892
+204
+1% +$9.04K 0.13% 85
2021
Q2 		$575K Buy
14,688
+463
+3% +$18K 0.12% 87
2021
Q1 		$515K Buy
14,225
+5
+0% +$178 0.12% 90
2020
Q4 		$523K Sell
14,220
-710
-5% -$26K 0.12% 91
2020
Q3 		$520K Sell
14,930
-2,155
-13% -$75.6K 0.14% 87
2020
Q2 		$530K Sell
17,085
-5,265
-24% -$179K 0.16% 80
2020
Q1 		$692K Buy
22,350
+8,437
+61% +$287K 0.3% 51
2019
Q4 		$517K Sell
13,913
-806
-5% -$28.7K 0.14% 67
2019
Q3 		$502K Sell
14,719
-349
-2% -$12.7K 0.14% 67
2019
Q2 		$619K Sell
15,068
-101
-0.7% -$4.01K 0.19% 62
2019
Q1 		$611K Buy
15,169
+5
+0% +$200 0.19% 62
2018
Q4 		$628K Buy
15,164
+490
+3% +$20.3K 0.23% 59
2018
Q3 		$613K Sell
14,674
-1,722
-11% -$66.3K 0.19% 59
2018
Q2 		$564K Sell
16,396
-106
-0.6% -$3.62K 0.19% 58
2018
Q1 		$556K Buy
16,502
+2,467
+18% +$84.8K 0.2% 62
2017
Q4 		$482K Sell
14,035
-203
-1% -$6.92K 0.17% 70
2017
Q3 		$482K Buy
14,238
+57
+0.4% +$1.83K 0.18% 71
2017
Q2 		$452K Buy
14,181
+217
+2% +$6.84K 0.18% 76
2017
Q1 		$453K Sell
13,964
-7
-0.1% -$221 0.19% 74
2016
Q4 		$431K Buy
13,971
+2,675
+24% +$81.7K 0.19% 69
2016
Q3 		$363K Buy
11,296
+592
+6% +$19.8K 0.18% 72
2016
Q2 		$357K Buy
10,704
+54
+0.5% +$1.72K 0.19% 67
2016
Q1 		$299K Hold
10,650
– – 0.16% 73
2015
Q4 		$326K Sell
10,650
-383
-3% -$12K 0.18% 70
2015
Q3 		$329K Buy
11,033
+142
+1% +$4.55K 0.2% 72
2015
Q2 		$346K Sell
10,891
-309
-3% -$10.1K 0.19% 69
2015
Q1 		$369K Sell
11,200
-2,163
-16% -$68.8K 0.21% 60
2014
Q4 		$395K Buy
+13,363
New +$383K 0.21% 71
2014
Q3 		– Sell
-11,457
Closed -$322K – 113
2014
Q2 		$322K Sell
11,457
-311
-3% -$8.87K 0.2% 73
2014
Q1 		$359K Sell
11,768
-10,568
-47% -$315K 0.25% 61
2013
Q4 		$649K Buy
22,336
+484
+2% +$14.1K 0.37% 62
2013
Q3 		$596K Sell
21,852
-8
-0% -$218 0.39% 59
2013
Q2 		$581K Buy
+21,860
New +$604K 0.4% 59

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

King Wealth Management Group's PFE Position: Q1 2026 in Review

King Wealth Management Group reduced its Pfizer (PFE) stake by 1.8% in Q1 2026, selling an estimated $9.48K and leaving 19,221 shares worth $540K. The position accounts for 0.07% of the portfolio, ranked #98.

King Wealth Management Group first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $929K in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • King Wealth Management Group held 19,221 shares of Pfizer worth $540K as of Q1 2026.
  • King Wealth Management Group sold 356 Pfizer shares in Q1 2026, an estimated $9.48K.
  • Pfizer made up 0.07% of King Wealth Management Group's portfolio in Q1 2026, its #98 holding.
  • King Wealth Management Group first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
  • King Wealth Management Group's Pfizer position peaked at $929K in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on King Wealth Management Group's 13F filing for Q1 2026, filed 4 May 2026.